이상반응 보고
| VAERS ID | 927703 |
|---|---|
| 성별 | 여성 |
| 나이 | 37세 |
| 주 코드 | FL |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | EH9899 |
| 예방접종 횟수 | 1 |
| 접종일 | 2020-12-18 |
| 발병일 | 2020-12-18 |
| 상태 |
증상
- 임신 중 노출(Exposure during pregnancy)
- SARS-CoV-2 테스트 양성(SARS-CoV-2 test positive)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
Test Date: 20201228; Test Name: Covid test; Test Result: Positive
증상 상세
tested positive for Covid a week after receiving the vaccine; tested positive for Covid a week after receiving the vaccine; patient stated that she was pregnant; patient stated that she was pregnant; patient stated that she was pregnant; This is a spontaneous report from a contactable nurse (patient) from a Pfizer sponsored program.
A 37-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EH9899), via an unspecified route of administration on 18Dec2020 at left deltoid for Covid-19 immunisation.
The patient medical history was not reported.
There were no concomitant medications.
The patient experienced tested positive for Covid a week after receiving the vaccine on 28Dec2020 (as reported), the patient stated that she was pregnant.
The patient underwent lab tests and procedures which included Covid test: positive on 28Dec2020.
The outcome of events was unknown.
; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded.
Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.